Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07469033

Prevalence of Misophonia in Turkish High School Students

Prevalence of Misophonia in Turkish High School Students: A Sample From Kayseri and Samsun

Status
Recruiting
Phase
Study type
Observational
Enrollment
600 (estimated)
Sponsor
Ondokuz Mayıs University · Academic / Other
Sex
All
Age
15 Years – 18 Years
Healthy volunteers
Accepted

Summary

This cross-sectional study aims to determine the prevalence of misophonia among high school students in Kayseri and Samsun, Turkey. Data will be collected using a sociodemographic data form and the Amsterdam Misophonia Scale-Revised (AMISOS-R). The study will evaluate the frequency and severity of misophonia symptoms and examine their association with demographic variables.

Detailed description

Misophonia is a condition characterized by decreased tolerance and heightened sensitivity to specific sounds. It is more closely related to the character of the sound than to its intensity and is often reported to begin during childhood or early adolescence. Misophonia may negatively affect students' social interactions and academic performance, particularly in school environments where exposure to auditory stimuli is unavoidable. This cross-sectional descriptive prevalence study aims to determine the prevalence and severity of misophonia among high school students in Kayseri and Samsun, Turkey. The study population will include students in grades 9 through 12 attending selected high schools. Students with hearing loss, chronic illness, severe psychological disorders, intellectual disabilities, or those outside the defined age range will be excluded. Data will be collected using a sociodemographic data form and the 10-item Amsterdam Misophonia Scale-Revised (AMISOS-R), a validated self-report instrument assessing the presence and severity of misophonia symptoms. Statistical analyses will be conducted to evaluate the distribution of misophonia symptoms and their associations with demographic variables. The study will be conducted in accordance with ethical principles.

Conditions

Timeline

Start date
2025-01-25
Primary completion
2026-04-01
Completion
2026-04-01
First posted
2026-03-13
Last updated
2026-03-13

Locations

2 sites across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT07469033. Inclusion in this directory is not an endorsement.